Introduction
TGFa (transforming growth factor a 1 ) is a member of the family of mitogenic, autocrine growth factors which show homology to epidermal growth factor (EGF) and, like EGF, exert their biological eects via the epidermal growth factor receptor (EGFr; Carpenter and Cohen, 1990; Derynck, 1992; Todaro et al., 1990) . TGFa is secreted as a 50 amino acid peptide following cleavage from a 160 (human) or 159 (rat) amino acid precursor (Derynck, 1988) although secretion of larger forms has been reported (Derynck, 1988; Watkins et al., 1988) . The precursor molecule can also exist as a transmembrane glycoprotein which has biological activity (Brachman et al., 1989; Anklesaria et al., 1990) .
The use of neutralizing antibodies to both TGFa and the EGFr, and TGFa antisense approaches have all demonstrated that TGFa is an autocrine growthstimulatory factor in colon carcinoma (Markowitz et al., 1990; Burgess, 1991, 1992; Ziober et al., 1993) as well as other tumors Ennis et al., 1989; Imanishi et al., 1989; Malden et al., 1989; Lee et al., 1991) . TGFa has also been shown to be an autocrine growth factor in normal cells (Markowitz et al., 1990; Malden et al., 1989; Coey et al., 1987; Madtes et al., 1988; Bates et al., 1990; Kudlow and Bjorge, 1990; Lewis et al., 1990) and during development (Wilcox and Derynck, 1988) . However, solid tumors generally produce higher levels of this growth factor than their normal counterparts .
Interestingly, activation of the EGFr by either TGFa or EGF stimulates TGFa production (Coey et al., 1987 (Coey et al., , 1992 Bjorge et al., 1989) . Addition of TGFa or EGF to cultured cells including keratinocytes, breast and colon carcinoma cells results in a time-and dose-dependent increase in TGFa mRNA production. Increased TGFa protein secretion into culture media is also observed with similar kinetics. Activation of the EGFr has been implicated in this autoinduction as neutralizing antibodies to EGFr inhibit both TGFa accumulation into the media and the growth of many types of tumor cells in vitro (Markowitz et al., 1990; Ennis et al., 1989; Imanishi et al., 1989) . Furthermore, overexpression of TGFa in the weakly tumorigenic colon carcinoma cell line GEO by stable transfection of a TGFa expression vector resulted in the isolation of clones with increased tumorigenicity both in vitro and in vivo (Ziober et al., 1993) . Signi®cantly, the increased TGFa expression from the vector resulted in induction of endogenous TGFa mRNA levels.
Despite the importance of TGFa autocrine activity and its consequent autoinduction as a growth stimulant in cancer cells, little is known of the molecular mechanisms controlling TGFa expression, particularly with regard to control of transcription. In order to study TGFa transcriptional regulation, we cloned a 2813 bp fragment of the human TGFa promoter (Saeki et al., 1991) . This fragment extended the TGFa promoter characterization by 1673 bp in the 5' direction over that reported by a previous group (Jakobovits et al., 1988) . Where sequence overlap occurs, the sequence is identical. The rat TGFa promoter has also been cloned and is highly homologous to the human TGFa promoter (Blasband et al., 1990) . The notable features of the TGFa promoter are that it is devoid of any CCAAT or TATA box sequences. There are several Sp-1 sites located within the proximal 600 bp of DNA. There are several potential AP-2 sites located in the more distal regions of the promoter between 7375 and 7850 (Jakobovits et al., 1988) . Since EGFr activation stimulates TGFa expression, the characterization of the EGF/TGFa response element within the human TGFa promoter is important in understanding the control of this gene. Raja and coworkers (Raja et al., 1991) , using TGFa promoterluciferase constructs, reported evidence indicating that EGF-responsiveness was located in the general region of 7373 to 759 bp of the TGFa promoter, but speci®c elements were not identi®ed, and no known consensus motifs are present in this region. Furthermore, as this area of the TGFa promoter shows no homology to other known EGF-responsive consensus sequences, it seemed likely that the EGF/TGFa response element in this gene would represent a novel response element. Therefore, starting with a series of deletion TGFa-CAT constructs ranging from 7370 to 7201, we undertook studies to identify this element.
The well dierentiated FET colon carcinoma cell line was employed for these studies. The FET cell line was derived from a well dierentiated primary tumor and has retained dierentiated characteristics in vitro (Brattain et al., 1984; Chantret et al., 1988; Mulder and Brattain, 1989a,b; Wan et al., 1988) . It has been adapted to growth in a completely chemically de®ned medium (Brattain et al., 1984) . This cell line expresses TGFa and EGFr and responds proliferatively to exogenous EGF (Mulder and Brattain, 1989a,b; Wan et al., 1988) . While exogenous EGF is not an absolute requirement for growth due to autocrine TGFa activity, optimal growth is achieved only when EGF is present in the Figure 1 Induction of TGFa transcriptional activity and mRNA by EGF. (a) FET clone 3, stably transfected with p2813-CAT, was grown to 60% con¯uency in serum-free medium minus EGF. Cells were then changed to serum-free medium containing 10 ng/ ml EGF and harvested at 1, 4 and 24 h for assay of CAT activity as described in Materials and methods. (b) Parental FET cells adapted to growth in serum-free medium without EGF were switched to medium containing 10 ng/ml EGF and harvested at 1, 4 and 24 h later for RNA quantitation by RNase protection analysis as described in Materials and methods. (c) Quantitation of the CAT assay media (Mulder and Brittain, 1989b) . Therefore the FET cell line represents an excellent model to study regulation of the TGFa promoter by activated EGFr.
In this report, we describe the use of deletion fragments of the TGFa promoter in chloramphenicol acetyltransferase (CAT) reporter-gene chimeras to localize the EGF/TGFa response element. Subsequently, we de®ned a 47 bp region which conferred EGF-responsiveness to heterologous promoter reporter constructs. Further analysis of this sequence identi®ed 25 bp of promoter which was responsive to EGF. Moreover, mutation/deletion analysis of this sequence identi®ed both putative repressor and activator functions in this region.
Results

Kinetics of induction of TGFa transcription by EGF
Initial studies were performed to con®rm the EGFtranscriptional responsiveness of the TGFa promoter in the FET cell line. The largest TGFa promoter construct p2813-CAT (containing the 2813 bp of TGFa promoter 5' to the translation start site) was stably transfected into FET cells. Following Neo selection and subsequent testing for CAT activity, clones were isolated and some of these cells were adapted to growth in serum-free medium lacking EGF. Experiments were performed with a typical clone, designated FET 3. Results obtained with this clone were similar to other clones stably transfected with p2813-CAT. The addition of EGF (10 ng/ml) to these cells resulted in very little change in TGFa promoter activity at 1 h but by 4 h CAT activity was increased 3 ± 4-fold (Figure 1a,c) and remained elevated at 24 h. In order to con®rm that these changes in promoter activity re¯ected changes in endogenous TGFa mRNA expression, we examined TGFa mRNA expression under similar conditions in the parental cell line. Following the addition of EGF to the parental cell line routinely grown in serum-free medium without EGF, the TGFa mRNA level showed little change at 1 h but was increased 2 ± 3.5-fold at 4 h ( Figure 1b) . The TGFa mRNA level returned to basal by 24 h. This apparent discrepancy in TGFa promoter activity versus TGFa mRNA expression may be explained by the extreme stability of the CAT mRNA. This responsiveness to EGF is also re¯ected by protein levels in FET cells. FET cells maintained in serum-free medium minus EGF express only 73+10 pg/ml of TGFa per 10 6 cells in 48 h (6+s.e.mean; n=3). However, the addition of EGF results in increased TGFa secretion to 274+39 pg/ml per 10 6 cells over a 48 h period. Therefore, the changes in activity of the TGFa promoter-CAT chimeras re¯ect changes seen in both the endogenous TGFa mRNA and protein levels of FET cells dierentially exposed to EGF and therefore, activation of the EGFr leads to transcriptional upregulation of TGFa.
Localization of the EGF/TGFa response element
As we had established that the TGFa promoter within FET cells was transcriptionally responsive to EGF, we then proceeded to de®ne the EGF-responsive region The CAT assay data from cells plated and grown in serum-free medium with (+) or without (7) EGF was quantitated on an Ambis. The p370-, p343-and p247-CAT constructs showed signi®cant induction in the presence of EGF (P50.05; denoted by asterisk). The p201-CAT construct showed similar activity in cells grown + or 7 EGF within the TGFa promoter. In order to de®ne the region of the TGFa promoter involved in EGF/TGFa responsiveness, a series of deletion constructs were transiently transfected into parental FET cells grown continuously in the absence of EGF. Exogenous EGF was added for the indicated times. An RSV-bgalactosidase construct was co-transfected to normalize for transfection eciency. A typical result of such an experiment is shown in Figure 2 . The TGFa promoter deletion constructs p370-, p343-and p247-CAT each show signi®cantly higher activity (P50.05, n=3) in the presence of exogenous EGF than in its absence (summarized in Table 1 ). In contrast, the p201-CAT, construct shows the same level of CAT activity in the presence or absence of EGF. Consequently, the EGF/TGFa response element appeared to be localized between 7201 and 7247 within the TGFa promoter, placing it in the same region as described by Raja et al. (1991) . It is also evident from Figure 2 that the basal level of transcription of the p201-CAT construct is much reduced compared to the p247-, p343-and p370-CAT constructs.
The EGF/TGFa cis-element confers EGF-responsiveness to a heterologous tk promoter
The region between 7201 and 7247 of the TGFa promoter contains no suitable restriction enzyme sites to allow further subcloning. Therefore, this 47 bp sequence was synthesized and cloned just upstream of the tk promoter in the pBLCAT2 vector as described in Materials and methods. This 47 bp sequence conferred EGF-responsiveness to the heterologous tk promoter (data not shown). This sequence produced a 2 ± 2.5-fold increase in CAT activity while the parental pBLCAT2 vector showed no response.
In order to further de®ne the EGF-responsive region of this promoter, two overlapping oligos spanning this region were synthesized. These sequences contained 7246 to 7220 designated (oligos 1/2) and 7225 to 7199 (designated oligos 3/4) of the TGFa sequence. As a control, oligonucleotides corresponding to the region 7202 to 7176 (designated oligos 5/6) which lies downstream of the EGF-responsive region were synthesized. These constructs were also tested for their ability to confer EGF-responsiveness to the heterologous tk promoter. All three oligo sequences conferred some increase in basal activity of the pBLCAT2 vector. However, only the construct pBL-(3/4)-tk-CAT showed increased CAT activity in the presence of EGF (Figure 3 ). The growth factor produced a 2 ± 2.5-fold increase in CAT activity. The activity of the pBL-(1/2)-tk-CAT and pBL-(5/6)-tk-CAT constructs showed no significant dierence in activity in the presence or absence of EGF (Table 2) .
In order to further investigate the properties of this EGF-responsive region, plasmids were isolated in which the oligo pair 3/4 was inserted in reverse Mean+s.e.mean n=3; *Denotes dierences by t-test Figure 3 Further localization and characterization of the EGF-response element. The heterologous construct p3/4-tk-CAT containing 7201 to 7225 of the TGFa promoter was transfected into FET cells maintained in serum-free medium minus EGF(7). Following transfection, half the cells were switched to medium containing EGF(+) and harvested for CAT assay 24 h later. The eect of EGF on the parental vector pBLCAT2 is shown as a control. The eect of EGF on two tandem sequences of oligonucleotide 3/4 inserted upstream of the promoter, p-5D-tk-CAT, is also shown orientation to the tk promoter (designated pBL-13R-tk-CAT) and in which two sets of the oligos were inserted upstream of the tk promoter, both in the correct orientation (designated pBL-5D-tk-CAT). Notably, multiple insertions of the 25 bp EGFresponsive region do not increase the responsiveness Figure 4 Eect of deletion of various sequence motifs within the EGF-response element on basal activity and EGF-responsiveness of the TGFa promoter construct p247-CAT. (a) CAT assay of the Null and GAGG deletion motifs. The CAT activity of the p247-CAT plasmid and the deletion vectors described (b) was measured in the presence (+) or absence (7) of EGF for 4 h following transient transfection into FET cells maintained in serum-free medium as described in Materials and methods. (b) Graphical representation of the basal activity and EGF-response of the deletion motif p247-CAT constructs. The sequence motifs deleted in each construct are shown on the left hand side of the panel. The boxed bp represent the deleted motif. The basal activity and EGFresponse of each construct is normalized to the activity of the p247-CAT construct in the absence of EGF (activity=100%). Data represents 6+s.e.mean (n=3) to EGF (Figure 3 and Table 2 ). A double-insertion of the sequence results in only a 1.7 ± 2.0-fold increase in CAT activity upon stimulation with EGF. This response is of the same order of magnitude but slightly decreased compared to a single sequence. Furthermore, when inserted in reverse orientation, the basal activity of the sequence is reduced approximately 50% compared to that of the correct orientation, and the reverse sequence does not respond to exogenous EGF (Table 2) .
Eect of deletion of sequence motifs within the context of the TGFa promoter
If the sequence contained within oligonucleotide 3/4 represented the EGF-response element, then deletion of this sequence from an EGF-responsive TGFa promoter construct should abolish the EGF-response. Using the Ex-Site protocol (Stratagene) a p247-CAT construct in which 18 bp of the sequence within oligonucleotide 3/4 was deleted (Figure 4b ), designated the p247-(null)- Figure 5 Graphical representation of the basal activity and EGF-responsiveness of the deleted/mutated EGF-response elementheterologous constructs. The deletion/mutation sequences within the 25 bp EGF-response element are shown on the left hand side of the ®gure. These deletion/mutation sequences were cloned upstream of the minimal AML 65 promoter in the pAML 65 -CAT vector. These constructs were transiently transfected into FET cells as described in Materials and methods and the CAT activity was assayed following change of medium with (+) or without (7) EGF for 4 h. CAT activity was normalized to that of the wild-type EGF-response element (oligonucleotide 3/4) in the absence of EGF (activity=100%). The data represents mean+s.e.mean (n=3). The activity of the pAML 65 -CAT construct is shown to verify the non-EGF-responsiveness of this parental construct. The stars indicate signi®cant (P50.05) response to EGF CAT construct, was generated. This null construct showed decreased basal activity compared to the p247-CAT vector in serum free medium minus EGF and showed no responsiveness to exogenous EGF ( Figure  4a,b) .
A series of sequential deletions throughout the 25 bp sequence of oligonucleotide 3/4 were also generated ( Figure 4b) . Deletion of the sequence TGACGG (designated the p247-(TGAC)-CAT construct) or the TAGC sequence (designated the p247-(TAGC)-CAT construct) resulted in constructs which showed very little eect on basal activity in the absence of EGF (a non-signi®cant decrease) but which no longer showed responsiveness to exogenous EGF Figure 6 Gel shift analysis of nuclear constructs prepared from EGF-treated FET cells. (a) Nuclear extracts were prepared from FET cells treated with EGF for 1 or 4 h or non-treated controls (Oh) as described in Materials and methods. These extracts were run against labeled oligonucleotide 3/4 and the -GAGG, -TGAC and -TAGC deletion sequences described in (Figure 4b) . The most striking eect on TGFa promoter activity was seen when the sequence GCGAGGAGG was deleted (the p247-(GAGG)-CAT construct). This construct showed a signi®cant 2 ± 2.5-fold increase in basal activity (Figure 4a,b) . Moreover, upon addition of exogenous EGF, a further signi®cant increase in promoter activity occurred. Therefore, the EGF-responsive region of the TGFa promoter appeared to contain both an EGF-responsive activator which might also be involved in the maintenance of basal promoter activity and a repressor of TGFa promoter activity. Eect of sequential 4 bp deletion within oligonucleotide 3/4 on heterologous promoter activity If the TGFa promoter does consist of adjacent activator and repressor sequences, these functions should also be apparent in the context of heterologous promoter constructs. For these experiments, a new heterologous promoter construct containing 65 bp of the AML 65 promoter was made as described in Materials and methods due to the high basal activity of the pBLCAT2 vector. This new heterologous promoter contains only a TATA sequence. Therefore, it has lower basal activity which facilitated not only detection of the EGF-response (which is generally only of approximately twofold magnitude) but also allowed for ready identi®cation of loss of repressor sequences. On transfection into the FET cell line, the pAML 65 -CAT construct showed no response to EGF when assayed over a 24 h time course (data not shown).
The sequence of the 4 bp deletions is shown on the left hand side of Figure 5 . Oligonucleotides were also synthesized with the corresponding sequence mutated to show that deletions were not spatially disrupting the sequence and so causing the eects. The three 4 bp motifs deleted or mutated within oligonucleotide 3/4 were based on the sequences of the p247-CAT deletions, shown in Figure 4b and designated (-GAGG), (-TGAC) and (-TAGC), respectively. The results were similar to the eect of deletions within the p247-CAT promoter construct and are presented graphically on the righthand side of Figure 5 . Speci®cally, deletion or mutation of the GAGG sequence again conferred an approximately twofold signi®cant increase on basal activity of the heterologous construct in the absence of EGF. Addition of exogenous EGF resulted in a further signi®cant increase in CAT activity. Deletion or mutation of the TGAC or TAGC sequences had no signi®cant eect on basal activity of the construct, although TGAC deletion caused a slight increase and TAGC deletion a slight decrease. Signi®cantly, deletion/mutation of either the TGAC or TAGC motifs resulted in the loss of EGF-responsiveness.
Gel shift analysis
In order to begin to study the trans-acting factors binding to this EGF-responsive element, and to determine whether this binding is regulated by EGF, nuclear extracts were prepared from FET cells grown in the absence of EGF or treated with EGF for 1 or 4 h for use in gel shift studies (Figure 6a ). When oligonucleotide 3/4 is used as probe several bands are seen (labeled 1 to 5). The lowest mobility, highest molecular weight bands represented by bands 1, 2 and 3 are particularly responsive to EGF, especially at 4 h following its addition. Band 4 shows a slight EGFresponse whereas band 5 does not. When completed with cold oligonucleotide 3/4, all but band 5 are competed suggesting this band represents non-speci®c binding (Figure 6b) .
We also ran the nuclear extracts using the deletion series of oligonucleotides as probe to determine whether speci®c bands of protein binding were associated with speci®c motifs (Figure 6a ). When the GAGG deletion sequence was used as probe, only band 2 and band 4 remained. Band 2 showed marked EGF-induction under these conditions. When the TAGC deletion oligonucleotide was used as probe, bands 1, 3 and 4 remained. In the case of the TGAC deletion, again bands 1, 3 and 4 were seen, but bands 1 and 3 were markedly reduced in intensity. As band 4 is present with all the deletion oligonucleotides whether EGF-responsive or not, it probably represents a basal transcription factor. To further test the binding speci®city of bands 1, 2 and 3, we ran competition studies using the 32 P-labeled GAGG and TAGC deletion oligonucleotides against smaller promoter fragments from the 25 bp EGF-responsive region (Figure 7a) . Band 2, which binds the GAGG deletion oligonucleotide and represents the putative activator binding activity is not competed by oligonucleotide D (Figures 7b and 8 ) which contains the repetitive GAGG sequence (CGAGGAGGTG). Interestingly, band 2 is only partially competed by the oligonucleotides B and C, which separately contain the TGAC and TAGC motifs (sequences GGAGTGACG and CGGTAGCCG, respectively). However, oligonucleotide AE (which is a slightly shorter version of the GAGG deletion oligonucleotide) and contains both the TGAC and TAGC motifs in their correct spatial relationship, completely inhibits binding of band 2 (Figure 7b) .
In Figure 7c , competition of the 32 P-labeled TAGC deletion oligonucleotide against oligonucleotide C and D is presented. The TAGC oligonucleotide binds bands 1 and 3, which represent putative repressor binding. Oligonucleotide D (containing the putative repressor binding sequence CGAGGAGGTG) completely competes away band 1, while band 3 binding is partially inhibited.
In contrast, oligonucleotide C (CGGTAGCCG) which does not contain the GAGG repressor motif, does not compete for either band 1 or 3. These studies suggest that the binding in band 1 clearly represents repressor binding while band 3 also play a role in repressor function. These gel shift studies clearly indicate the presence of activator and repressor binding which each show distinct binding speci®cities.
Discussion
TGFa is an autocrine growth regulator in normal cells and overexpression of this growth factor contributes to the loss of growth regulation and development of tumorigenicity in the transformed phenotype in colon cancer cells (Ziober et al., 1993) . The importance of EGFr activation in the regulation of TGFa, either by EGF or TGFa itself, has been established by the use of EGFr antibodies (Markowitz et al., 1990; Ennis et al., 1989; Imanishi et al., 1989) . Although the TGFa promoter has been isolated, little is known about the mechanism of response to EGFr activation. Therefore, studies were initiated to identify the DNA sequence involved. In this paper we report the localization of this EGF/TGFa response element to a 25 bp region between 7225 and 7201 of the TGFa promoter. This ®nding is in agreement with previous ®ndings that localized EGF-responsiveness to the ®rst 313 bp of the 5'-¯anking sequence of the TGFa promoter using a TGFa promoter-luciferase construct (Raja et al., 1991) . The ability of this 25 bp fragment to confer EGF-responsiveness to both the heterologous tk and AML 65 promoters indicated that it is an enhancer-type element. The evidence with the ®rst 65 bp of the AML promoter is particularly convincing since this region contains only a TATA box element.
The level of induction of TGFa mRNA by EGF reported in this study is in agreement with previous results (Howell et al., 1995; Coey et al., 1987 Coey et al., , 1992 Bjorge et al., 1989) . Similarly, the gastrin gene which is transcriptionally responsive to EGF, shows only a maximal threefold increase in both mRNA levels and promoter activity following stimulation by the growth factor (Merchant et al., 1991) . Although EGF eects a wide range of biological action, it produces only relatively small increases in individual gene activity. This EGF response element, as well as regulating responses to exogenous EGF, must be important in TGFa autoregulation, and so constitutes part of the TGFa autocrine loop. The transcription factors binding to these sites therefore represent downstream eector molecules of EGFr activation, both due to exogenous EGF and endogenous TGFa. Whether these transcription factors regulate other genes involved in the mitogenic response to EGFr activation remains to be determined.
This study also suggests the importance of the TGFa-autoregulatory element in regulating basal expression of the TGFa promoter. Deletion to 201 bp of TGFa promoter which removes the adjacent EGF/ TGFa response element, signi®cantly decreases the level of basal CAT activity. Other groups have also reported that deletions which remove this element result in CAT constructs with reduced basal activity (Jakobovits et al., 1988; Raja et al., 1991) . Therefore, this EGF/TGFa response element may also be important in maintaining a level of TGFa basal transcription which facilitates the action of more distal (`upstream') elements. Deletion of the ®rst 370 bp of DNA to generate a construct extending from 71140 to 7370 yields very low CAT activity (only 5% of the total activity) despite the presence of several potential Sp-1 and AP-2 sites within this fragment (Jakobovits et al., 1988 ). The remaining low-level basal transcription of the p201-CAT construct is probably due to Sp-1 binding at the two potential Sp-1 consensus sequences within this region. The presence of Sp-1 sites within this region of the rat TGFa promoter which are required for basal transcription has been reported previously (Chen et al., 1992) .
The results of this study indicate that this EGFresponse element comprises binding sites for both a transcriptional activator and repressor. The GAGG motif within the EGF-response element appears to bind a repressor activity which appears to control basal expression of the TGFa promoter. Gel shift analysis indicates that protein binding in the bands which appear to represent the repressor complexes is also EGF-regulated. Therefore, as well as functioning to maintain low basal levels of TGFa, the repressor may also represent a feedback mechanism to regulate the level of response to TGFa to exogenous growth factors as well as the positive stimulation of TGFa promoter activity by the autocrine pathway.
We have also identi®ed two motifs within the 25 bp sequence, TGAC and TAGC, which are necessary for EGF/TGFa stimulation of TGFa promoter activity. Gel shift analysis reveals that both motifs are required for optimal binding of the activator which is positively regulated by EGF. Interestingly, the gel shift competition binding studies on the activator binding re¯ect the TGFa promoter activity exhibited by the deletion constructs. Optimal TGFa promoter activity and optimal activator protein binding is observed when the GAGG sequence is deleted leaving both the TAGC and TGAC motifs (the GAGG deletion oligonucleotide). This oligonucleotide has high basal activity, and as activator binding is responsive to EGF, activity is further stimulated by EGF. In contrast, neither the TGAC or TAGC notifs alone compete eectively for activator binding and so both the TAGC and TGAC deletion oligonucleotides have very low basal activity with very little or no eect of EGF. Thus, both the TAGC and TGAC motifs are required for activator binding and the presence of at least a part of the TGAC motif is also necessary for repressor binding. This activator must also act to oset the eect of the repressor and maintain some low level of TGFa promoter activity.
The multi-complex nature of this EGF-response element probably accounts for the fact that this cissequence does not show all the properties of an enhancer. While this element can confer EGFresponsiveness to a heterologous promoter, it does not function in reverse orientation. Moreover, two of the EGF-response elements in tandem do not increase the level of response to exogenous EGF, probably because as well as aligning two activator sites, two repressor sites are also brought into tandem. This multi-complex regulation of a growth factor gene is not unique. Regulation of the c-fos gene by mitogens is also eected by interactions of adjacent transcription factors (Dalton et al., 1993; Treisman, 1994; Price et al., 1995) . Transcription of the c-fos gene is stimulated by the serum response factor (SRF) bound to the SRF site and by ternary complex factor (TCF) bound at an adjacent site which contains an Ets transcription factor motif. TCF cannot bind independently of SRF. While the SRF alone can mediate response to serum, the presence of TCF is required for activation of c-fos transcription in response to individual growth factor signaling pathways. Therefore, a complex array of cisand trans-acting factors presumably allows for the in¯uence of many pathways to converge at a single regulatory region. These eects on the trans-acting factors could be both transcriptional and/or posttranslational aecting, for example, phosphorylation state. In the case of the TGFa gene, interaction between transcriptional activators and repressors in this region might also be a mechanism for regulating expression of this potentially transforming gene within tight limits.
The DNA sequence of the EGF/TGFa responsive region of the TGFa promoter does not show homology to other known EGF/TGFa response elements which have been identi®ed. Other EGF/TGFa responsive elements include the AP-1 transcription factor which has the minimal consensus sequence TGACTCA and binds jun family homodimers or jun ± fos heterodimers (Angel et al., 1987; Fisch et al., 1989; Curran and Franza, 1988; McDonnell et al., 1990) . Moreover, GCrich motifs have also been reported to mediate EGF-responsiveness as in the Egr-1 (Cao et al., 1990; Sukhatme, 1991) and gastrin (Merchant et al., 1991) genes. These GC-rich motifs show weak homology to the consensus sequence for the transcription factor AP-2 which can mediate induction by both the cyclic AMP and protein kinase C pathways . However, it is unlikely that they are true AP-2 sites as they are only weakly induced by phorbol esters. Another class of EGF-response element is that shared by the prolactin and tyrosine hydroxylase genes (Elsholtz et al., 1986; Lewis and Chikaraiski, 1987) . The two motifs in these genes are very similar but show no homology to the other EGF-response elements or the EGF-response element reported here.
The reason for the diversity of EGF-responsive motifs remains to be determined. The AP-1 and cAMP-responsive elements control a wide range of gene responses by binding homodimers or heterodimers of transcription factor families (Curran and Franza, 1988; Zi, 1990; Brindle and Montminy, 1992) . Activation of the EGFr stimulates a wide range of responses, encompassing proliferative, dierentiation and developmental eects. Furthermore, the EGF family encompasses a growing number of members including amphiregulin and cripto which also interact with the EGFr (Carpenter and Cohen, 1990; Derynck, 1992; Todaro et al., 1990) . Diverse EGF/TGFa ciselements would be one way to encompass the range of EGF/TGFa (and indeed other EGF family members) eects on gene transcription. This would certainly allow for diversity in temporal induction of eects, especially those involved in precise cell-cycle regulation.
Materials and methods
Cell culture
The FET cell line is routinely maintained in a de®ned serumfree medium as previously described (Mulder and Britain, 1989b; Wan et al., 1988; Boyd et al., 1988) . This consists of McCoy's 5A medium (Sigma) supplemented with amino acids, pyruvate, antibiotics and the growth factors insulin (20 mg/ml; Sigma), transferrin (4 mg/ml; Sigma) and EGF (10 ng/ml; R&D Systems). However, in order to maximize EGF-responsiveness, EGF was omitted from the medium in which cells were maintained and experiments were performed after changing cultures to serum-free medium containing EGF for the stated times. Working cultures were maintained at 378C in the presence of 5% CO 2 . Cells were subcultured using 0.25% trypsin in Joklik's medium (Gibco) containing 0.1% EDTA and replated in serum-free medium.
Cloning of the TGFa promoter
A normal human leukocyte genomic library (Clonetech) was screend by plaque hybridization (Maniatis et al., 1982) with a probe homologous to the TGFa coding sequence +104 to +129 (based on the published TGFa cDNA sequence; Derynck, 1988) . A 2.8 kb PstI ± SnaBI fragment containing the TGFa promoter sequence and the ®rst 125 bp of coding sequence was isolated (Saeki et al., 1991) . Following removal of the coding sequence with Ba131 exonuclease (to nucleotide 74), the resulting fragment was cloned upstream of the bacterial CAT gene in the vector pGCAT, to give the largest construct designated p2813-CAT. By the use of appropriate restriction sites or the PCR technique, deletion fragments of the TGFa promoter were generated and inserted upstream of the bacterial CAT gene in the vector pGCAT-C.
Cell transfection and isolation of stable transfectants
Con¯uent FET cells were harvested by trypsinization and resuspended at 2610 7 cells per 800 ml of serum-free medium without EGF and transferred to a 0.4 cm electro gap cuvette. Cells were electroporated at 250 volts and 960 mFarads in a BioRad gene pulser with 50 mg TGFa-promoter-CAT construct. In transient transfection assays, an RSV-bgalactosidase reporter gene (20 mg) was co-transfected to monitor transfection eciency). Transfected cells were plated in two dishes in serum-free medium without EGF and changed 12 h later. Cells were harvested at 36 to 48 h after transfection following addition of EGF for the stated times. Stable clones containing TGFa-promoter CAT constructs were transfected as described above with 30 mg vector and 5 mg of an SV-40-Neomycin (Neo) plasmid and plated at 1 : 20 ± 1 : 30 dilution. Two days following plating, cells were switched to medium containing 600 mg/ml Geneticin (G418; Gibco) to allow selection for Neo resistant clones. These clones were expanded and tested for CAT expression.
CAT assays
Following three washes in phosphate buered saline, cells were harvested in 1 ml of TEN buer (40 mM Tris, pH 7.4, 1 mM EDTA and 150 mM NaCl) and following centrifugation, resuspended in 100 ml of 250 mM Tris-HCl, pH 7.8 containing 15% glycerol (v/v) and lysed by three cycles of freeze-thawing. Protein concentration in the lysate was determined by microassay using bicinchoninic acid reagent (Pierce). The b-galactosidase activity was determined by macroassay as described by Promega. Cell lysates were added to the CAT assay corrected for b-galactosidase activity. The CAT assay was performed in a ®nal volume of 164 ml in 250 mM Tris-HCl, pH 7.8, containing 0.2 mCi [ 
Design of the heterologous promoter-CAT constructs
The 47 bp of DNA sequence (both strands) corresponding to 7201 to 7247 of the TGFa promoter were synthesized with BamHI`sticky ends' and were inserted in the BamHI site just upstream of the thymidine kinase tk promoter in the pBLCAT2 vector. Subsequently, three other sets of overlapping oligos spanning 7246 to 7220 (sense and antisense strand; oligo 1/2), 7225 to 7199 (oligo 3/4) and 7202 to 7176 (oligo 5/6) were synthesized according to the TGFa promoter sequence in reference 25 and also cloned into the pBLCAT2 vector.
While the heterologous tk constructs based on the pBLCAT2 vector were used in initial characterizations of the EGF-response element, we switched to another construct in the more detailed analyses. This was because of the high background activity of the tk promoter. Therefore, we synthesized the ®rst 65 bp of the adenonous major late (AML 65 ) promoter (755 to +10) with BamHI and XhoI ends. The promoter within the pBLCAT2 vector was excised with BamHI and XhoI and the AML 65 sequence was inserted in this site, generating a vector designated pAML 65 -CAT. This 65 bp region contains only a TATA box and no other known consensus regions.
RNA preparation
Total RNA was isolated by the method of Chirgwin et al. (1979) using a cesium tri¯uoroacetic acid gradient (Pharmacia).
RNase protection assay
To obtain a speci®c TGFa probe, a 306 bp EcoRI ± SphI fragment of TGFa cDNA was cloned into the pGEM 3Z(-) vector (Promega). High speci®c activity riboprobe was synthesized in the presence of [ 32 P]UTP (3000 Ci/Mmol; NEN) by SP6-RNA polymerase. Following DNaseI digestion of the DNA template, the riboprobe was isolated on a Nacs-52 column (Gibco BRL).
Total RNA (20 ± 40 mg) was hybridized to the riboprobe overnight in 5 M guanidine isothiocyanate (pH 7.0) containing 0.1 M EDTA as described previously (Howell et al., 1995) . Following RNase digestion of excess riboprobe, protected fragment was electrophoresed on a 6% ureapolyacrylamide sequencing gel. Equal loading of the gel was determined by simultaneous hybridization of the RNA with an actin probe transcribed from the BamHI ± HindIII fragment of a-actin (Enoch et al., 1986) inserted in the pGEM 3Z(-) vector and linearized with HinfI. This probe yields a 145 bp protected fragment when hybridized with human actin.
Protein assay
The TGFa protein was quantitated using the quantitative ELISA kit from Oncogene Science.
Gel retardation assay
Nuclei were prepared from FET cells by hypotonic lysis as described by Dignam et al. (1983) . Nuclear proteins were saltextracted and concentrated as described by Gorski et al. (1986) and aliquots were snap-frozen in liquid N 2 and stored at 7808C.
High speci®c activity double-stranded oligonucleotide labeled with 32 P-dGTP by Klenow (Promega) was incubated with nuclear extracts in a ®nal volume of 20 ml as described previously (Gorski et al., 1986) . Following incubation on ice, the reaction mix was loaded onto a 4% polyacrylamide gel in 25 mM Tris-25 mM boric acid buer containing 0.5 mM EDTA and run at 150 ± 250 V at 48C (Scheidereit et al., 1987) . In order to test the binding speci®cities of the protein complexes, competition experiments were performed. Increasing concentrations of unlabeled oligonucleotides (5 ± 100 ng) were added to incubations of 32 P labeled probe (oligonucleotide 3/4, deletion versions of 3/4) in the presence of nuclear extract from EGF-treated cells.
Abbreviations TGFa, transforming growth factor a; EGF, epidermal growth factor; EGFr, epidermal growth factor receptor; bp, base pair(s); CAT, chloramphenicol acetyltransferase; tk, thymidine kinase; cAMP, cyclic adenosine monophosphate; Neo, Neomycn; PCR, polymerase chain reaction.
